Literature DB >> 7047392

Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.

T I Doran, S J Mattingly.   

Abstract

The type-specific antigens (TSA) of group B streptococcus (GBS) represent the primary virulence factors for these organisms, yet little is known about their relationship to the cell surface of GBS. Crude cell walls of serotype III GBS strain 110 were purified by extraction with sodium dodecyl sulfate, LiCl, and urea, which removed essentially all of the protein associated with the cell wall as determined by amino acid analysis. Only those amino acids found in peptidoglycan were present, which included alanine, lysine, and glutamate (3.5:1:1 molar ratio). In contrast, these procedures resulted in the release of only 4.6% of the wall-associated TSA, indicating that protein was not the primary means by which TSA was bound to the cell surface. Mutanolysin (20 micrograms/ml) treatment of purified cell walls resulted in the release of 95% of the wall-associated TSA. The covalent association of TSA, the group B polysaccharide, and the peptidoglycan was demonstrated by the presence of N-acetylmuramic acid, rhamnose, alanine, glutamate, and lysine in mutanolysin-extracted TSA material purified by DEAE-Sephacel anion exchange and Sepharose 4B gel chromatography. Chemical analysis of purified cell walls revealed that group B antigen and peptidoglycan comprised 37.4 and 36.5%, respectively, whereas TSA accounted for 22.1 to 24.5% of the weight of the purified walls. Of the total 283.5 mg of TSA produced per 10-liter culture of GBS strain 110, 8.4% was released into the supernatant fluid. The remainder (249 mg) comprised the cell wall antigen. As described above, 4.6% of the cell wall antigen was extractable by nonenzymatic methods, which represented 3.8% of the total TSA, whereas 87.8% of the total TSA produced appeared to be covalently attached to the cell wall.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7047392      PMCID: PMC551446          DOI: 10.1128/iai.36.3.1115-1122.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Group B streptococcal neonatal and infant infections.

Authors:  R A Franciosi; J D Knostman; R A Zimmerman
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

2.  Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants.

Authors:  C J Baker; F F Barrett; R C Gordon; M D Yow
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

3.  Cellular and humoral immune response to group B streptococci.

Authors:  P H Klesius; R A Zimmerman; J H Mathews; D H Krushak
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

4.  Opsonin system of the group B streptococcus.

Authors:  J H Mathews; P H Klesius; R A Zimmerman
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

Review 5.  Covalent lipoprotein from the outer membrane of Escherichia coli.

Authors:  V Braun
Journal:  Biochim Biophys Acta       Date:  1975-10-31

6.  Studies on the immunochemistry of streptococcal mucopeptide.

Authors:  W W Karakawa; R M Krause
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

7.  Studies on the linkage between teichoic acid and peptidoglycan in a bacteriophage-resistant mutant of Staphylococcus aureus H.

Authors:  J E Heckels; A R Archibald; J Baddiley
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

8.  Type-specific antigens of group B type Ic streptococci.

Authors:  H W Wilkinson; R G Eagon
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

9.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

10.  Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus.

Authors:  C J Baker; D L Kasper; C E Davis
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

View more
  13 in total

1.  Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products.

Authors:  M Cuzzola; G Mancuso; C Beninati; C Biondo; C von Hunolstein; G Orefici; T Espevik; T H Flo; G Teti
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico.

Authors:  G C Palacios; E K Eskew; F Solorzano; S J Mattingly
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

3.  Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.

Authors:  T Lagergard; J Shiloach; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

4.  Structure of the Bacillus anthracis dTDP-L-rhamnose-biosynthetic enzyme glucose-1-phosphate thymidylyltransferase (RfbA).

Authors:  Jackson Baumgartner; Jesi Lee; Andrei S Halavaty; George Minasov; Wayne F Anderson; Misty L Kuhn
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-10-30       Impact factor: 1.056

5.  Biosynthesis of cell wall peptidoglycan and polysaccharide antigens by protoplasts of type III group B Streptococcus.

Authors:  M K Yeung; S J Mattingly
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

6.  Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

7.  Comparative analysis of the localization of lipoteichoic acid in Streptococcus agalactiae and Streptococcus pyogenes.

Authors:  S J Mattingly; B P Johnston
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

8.  Isolation, chemical composition, and molecular size of extracellular type II and type Ia polysaccharides of group B streptococci.

Authors:  B J De Cueninck; T F Greber; T K Eisenstein; R M Swenson; G D Shockman
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

9.  Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.

Authors:  M R Wessels; W J Benedí; H J Jennings; F Michon; J L DiFabio; D L Kasper
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.